Zydus Wellness Ltd reports Rs 133 13 crore consolidated PAT in Q4FY21 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Zydus Wellness FY21 net profit falls 16% to Rs 119 cr
For January-March quarter, the consumer wellness company s net profit grew over 92 per cent to Rs 133 crore, while total revenue rose 24 per cent to Rs 608 crore.
BusinessToday.In | May 10, 2021 | Updated 16:11 IST
During the quarter, the company also forayed in the dairy segment with launch of two new products under the Nutralite brand.
Zydus Wellness on Monday reported a 16 per cent year-on-year decline in its consolidated net profit for financial year 2020-21 at Rs 119 crore.
The company s net profit would have been about 35 per cent higher at Rs 251 crore if not for exceptional item of Rs 132 crore during the year.
Zydus Wellness reported 92.7% jump in net profit to Rs 133.13 crore in Q4 FY21 from Rs 69.10 crore in Q4 FY20.
Net sales rose 23.9% to Rs 600.75 crore in Q4 FY21 over Q4 FY20. EBIDTA increased by 39% year-on-year (YoY) to Rs. 145.40 crore in the fourth quarter. Profit before tax in Q4 March 2021 stood at Rs 132.66 crore, up by 115.8% from Rs 61.47 crore in the same period last year.
The company reported 16.2% drop in consolidated net profit to Rs 118.73 crore on 6.9% rise in net sales to Rs 1,853.66 crore in the year ended 31 March 2021 over the year ended 31 March 2020.
During FY21, the company incurred an exceptional expenditure of Rs 132.13 crore.
Q3FY21 Result Update - Zydus Wellness - ICICI Direct
Posted On: 2021-02-02 22:26:17 (Time Zone: Arizona, USA)
Zydus wellness (ZWL) posted strong Q3FY21 results with 15.6% growth in net sales led by double digit growth in Sugarfree & healthy growth across segments (except Nutralite). With the increased health awareness, Sugarfree has been witnessing strong growth in the last three quarters. The company is trying to leverage this trend by introducing newer variants and is also aggressively spending towards brand building through digital campaigns. Further, it maintained its leadership position in Glucon D, EverYuth Scrub & Nycil with market share of 58.3%, 34.8% & 35.7%, respectively. Gross margins expanded 262 bps on account of significant decline in milk prices. The continuous exercise of cost cutting measures resulted in overhead savings of 362 bps & integration of acquired business results in lower employee cost 113 bps. The company aggressively increased its marketing spe
Zydus Wellness Ltd reports Q3FY21 earnings
Posted On: 2021-02-01 10:02:38 (Time Zone: Arizona, USA)
Zydus Wellness Ltd., announced results for the third quarter ended 31st December 2020. The company reported 15.6% growth in consolidated net sales which stood at Rs.3764 million. The Company reported consolidated income from operations at Rs.3816 million, up by 14.7%. EBIDTA was up by 32.7% y-o-y to Rs.495 Million. In line with its strategic initiatives to pare down the debt, the Company during the quarter has fully redeemed Nonconvertible debentures of Rs.15000 million. In the process of buying back its own Nonconvertible debentures the Company has paid one-time debenture redemption premium Rs.1321 million out of which Rs.342 million is recorded as exceptional item in our financials for the current quarter. As a result of this exceptional item the Profit after Tax (PAT) stood at Rs.17 million for the quarter.